Skip to main content
CG MedTech Co.,Ltd. logo

CG MedTech Co.,Ltd. — Investor Relations & Filings

Ticker · 056090 ISIN · KR7056090004 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2026-01-12 Board/Management Inform…
Country KR South Korea
Listing KO 056090

About CG MedTech Co.,Ltd.

https://cgmedt.com/

CG MedTech Co., Ltd. is a medical technology company that designs, manufactures, and distributes orthopedic medical devices and surgical implants. The company's product portfolio encompasses solutions for spine, trauma, pain management, sports medicine, and biologics. Key offerings include spinal fixation devices, bioabsorbable alloy implants, and systems for fracture treatment. CG MedTech focuses on regenerative medicine and the development of innovative technologies, such as patient-specific 3D printed implants, to enhance tissue regeneration and improve patient outcomes.

Recent filings

Filing Released Lang Actions
최대주주변경
Board/Management Information Classification · 95% confidence The document is a formal regulatory filing regarding a change in the company's largest shareholder (최대주주변경). It details the change from '주식회사 에이하나' to '주식회사 시지바이오' due to a corporate spin-off (물적분할). Since this is a specific regulatory announcement regarding corporate structure and shareholding control that does not fit into categories like 'Major Shareholding Notification' (which usually refers to external investors crossing thresholds) or 'Director's Dealing', it is classified as a general regulatory filing.
2026-01-12 Korean
기타시장안내(최대주주의의무보유관련)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the KOSDAQ exchange regarding a change in the major shareholder of 'Cigi Meditech' and the subsequent mandatory holding requirements for the new shareholder. It is a regulatory announcement concerning market rules and compliance, not a financial report or a specific corporate action like a dividend or share buyback. Given it is a regulatory notification regarding market listing rules, it falls under the RNS category.
2026-01-12 Korean
[기재정정]신규시설투자등(자율공시)
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement regarding a change in investment amount for a new facility investment by the company. It includes details such as investment amount, purpose, period, board resolution date, and other relevant information. The document is short (1588 characters) and is a voluntary disclosure (자율공시) about capital expenditure changes, not a financial report or earnings release. It does not contain financial statements or detailed financial analysis. It is an update on capital investment activities, fitting the category of Capital/Financing Update (CAP).
2025-11-04 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '㈜시지메드텍' (CG MedTech Co., Ltd.) covering the period from 2025.01.01 to 2025.06.30. It contains detailed corporate information, history, capital structure, and governance details, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself, containing substantive data. H1 2025
2025-08-14 Korean
[기재정정]신규시설투자등(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (CG Medtech) regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment amount and project timeline due to design modifications. Since this is a specific regulatory disclosure regarding capital expenditure and corporate investment strategy that does not fit into the other specialized categories like M&A or Share Issues, it is classified as a Regulatory Filing (RNS).
2025-08-12 Korean
합병등종료보고서(합병)
M&A Activity Classification · 100% confidence The document is titled '합병등종료보고서' (Report on Completion of Merger, etc.) and is filed with the Financial Supervisory Service (FSS). It details the finalization of a merger between CGMedTech and its subsidiary GDS, including the timeline, shareholder dissent, creditor protection, and pro-forma financial statements post-merger. This document is a formal regulatory filing regarding M&A activity completion, which falls under the 'TAR' (M&A Activity) category.
2025-05-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.